SCHEMBL29607358

SCHEMBL29607358

COc1cccc(/C=N\N=C(\N)NO)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.74
CHRM5 P08912 1/20 0.64
FURIN P09958 2/20 0.51
GRIN1 Q05586 4/20 0.48
GRIN2B Q13224 4/20 0.48
GRIN2D O15399 3/20 0.48
GRIN3B O60391 3/20 0.48
GRIN2A Q12879 3/20 0.48
GRIN2C Q14957 3/20 0.48
GRIN3A Q8TCU5 3/20 0.48
CYP19A1 P11511 1/20 0.47
RELA Q04206 1/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
RECQL P46063 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1654602 0.79 CHRM5 (1.00) TAAR1CHRM5CYP19A1RELANPC1
SCHEMBL6953458 0.79 TAAR1 (0.72) TAAR1CHRM5FURINGRIN1GRIN2B
SCHEMBL6953452 0.79 TAAR1 (0.72) TAAR1CHRM5FURINGRIN1GRIN2B
SCHEMBL6953455 0.79 TAAR1 (0.72) TAAR1CHRM5FURINGRIN1GRIN2B
SCHEMBL11695628 0.76 GRIN2D (0.66) TAAR1FURINGRIN1GRIN2BGRIN2D
SCHEMBL24211889 0.74 TAAR1 (0.57) TAAR1CHRM5NPC1MAPTRAB9A
SCHEMBL13673520 0.74 TAAR1 (0.57) TAAR1CHRM5NPC1MAPTRAB9A
SCHEMBL2121150 0.73 CHRM5 (0.72) TAAR1CHRM5CYP19A1RELANPC1
SCHEMBL14950238 0.73 CHRM5 (0.72) TAAR1CHRM5CYP19A1RELANPC1
SCHEMBL31182402 0.73 CHRM5 (0.72) TAAR1CHRM5CYP19A1RELANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117946213-A Peptides for treating cancer 中山医学大学 2024-04-30 CN claimed
US-20250108038-A1 SUBSTITUTED DERIVATIVES OF ISOINDOLES AND USES THEREOF SUPERNUS PHARMACEUTICALS, INC. (US) 2025-04-03 US disclosed
CN-119651506-A Power distribution network protection method and device suitable for high-proportion distributed power supply access 国网重庆市电力公司忠县供电分公司 2025-03-18 CN disclosed
CN-119575068-A Method and system for rapidly measuring and positioning faults of 10kV power grid 深圳供电局有限公司 2025-03-07 CN disclosed
CN-114694379-B Traffic flow prediction method and system based on self-adaptive dynamic graph convolution 中山大学 2024-05-03 CN disclosed
CN-117946213-A Peptides for treating cancer 中山医学大学 2024-04-30 CN disclosed
CN-111032679-B Peptides for treating cancer 中山医学大学 2024-04-12 CN disclosed
US-20230404870-A1 A FLUORIDE DENTIFRICE CONTAINING AN IODINE COMPONENT ADVANTAGE SILVER DENTAL ARREST, LLC (US) 2023-12-21 US disclosed
CN-117024521-A DEC205 affinity peptide, coding nucleic acid and application thereof 郑州大学 2023-11-10 CN disclosed
EP-4237098-A1 A FLUORIDE DENTIFRICE CONTAINING AN IODINE COMPONENT Advantage Silver Dental Arrest, LLC (US) 2023-09-06 EP disclosed
US-20220313592-A1 Liquid Thickener Composition Comprising Polyalkoxylated APPLECHEM INC. (US) 2022-10-06 US disclosed
CN-114694379-A Traffic flow prediction method and system based on self-adaptive dynamic graph convolution 中山大学 2022-07-01 CN disclosed
CN-112830995-B Control method for polymerization reaction in carbon fiber production 荣成碳纤维科技有限公司 2022-06-17 CN disclosed
WO-2022103948-A1 A FLUORIDE DENTIFRICE CONTAINING AN IODINE COMPONENT ADVANTAGE SILVER DENTAL ARREST, LLC (US) 2022-05-19 WO disclosed
CN-114397478-A Single-axis differential resonant beam gauge outfit module and accelerometer 华中光电技术研究所(中国船舶重工集团公司第七一七研究所) 2022-04-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250108038-A1 SUBSTITUTED DERIVATIVES OF ISOINDOLES AND USES THEREOF NLN, TPH2, INA TAAR1 1175/4885CHRM5 316/4885FURIN 3689/4885
US-20220313592-A1 Liquid Thickener Composition Comprising Polyalkoxylated OGT, QPCT, AQP1 TAAR1 3341/4885CHRM5 2241/4885FURIN 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.